How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment: A Scoping Review

References

• Luz A, Santatiwongchai B, Pattanaphesaj J, et al. Identifying priority methodological issues in economic evaluation in low- and middle-income countries: finding the holy grail. http://gear4healthcom/gear. 2017.
   Google Scholar
• O’Rourke B, Oortwijn W, Schuller T. The new definition of health technology assessment: a milestone in international collaboration. Int J Technol Assess Health Care. 2020;36(1):1–4.
   PubMedGoogle Scholar
• Glassman A, Giedion U, Smith PC. What’s in, what’s out: designing benefits for universal health coverage. Washington DC: Center for Global Development; 2017.
   Google Scholar
• Grieve E, Hesselgreaves H, Wu O, et al. The Value of Health Technology Assessment: a mixed methods framework [version 1; not peer reviewed]. F1000res 2017, 6:2171 ( document) 10.7490/f1000research.1115169.1
   Google Scholar
• Stevens AJ, Longson C. At the center of health care policy making: the use of health technology assessment at NICE. Med Decis Mak. 2013;33(3):320–324.
   PubMed Web of Science ®Google Scholar
• Hailey D. The history of health technology assessment in Australia. Int J Technol Assess Health Care. 2009;25(S1):61–67.
   PubMedGoogle Scholar
• O’Donnell JC, Pham SV, Pashos CL, et al. Health technology assessment: lessons Learned from around the world—an overview. Value Health. 2009;12:S1–S5.
   PubMed Web of Science ®Google Scholar
• PAHO. Resolution CSP28.R9: health Technology Assessment and Incorporation into Health Systems. 2012.
   Google Scholar
• WHA. Resolution WHA67.3: health interventions and technology assessment in support of universal health coverage. 2014.
   Google Scholar
• WHO. Resolution SEA/RC66/R4: health intervention and technology assessment in support of universal health coverage. 2013.
   Google Scholar
• Piemonte C, Cattaneo O, Morris R, et al. Transition Finance: introducing a new concept. 2019. OECD Development Co-operation Working Papers, No. 54, OECD Publishing, Paris. https://doi.org/10.1787/2dad64fb-en.
   Google Scholar
• Hollingworth S, Gyansa-Lutterodt M, Dsane-Selby L, et al. Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process. Int J Technol Assess Health Care. 2020;36(1):8–11.
   PubMed Web of Science ®Google Scholar
• Gad M, Lord J, Chalkidou K, et al. Supporting the development of evidence-informed policy options: an economic evaluation of hypertension management in Ghana. Value Health. 2020;23(2):171–179.
   PubMed Web of Science ®Google Scholar
• iDSI. international Decision Support Initiative [ Available from: https://idsihealth.org/.
   Google Scholar
• Wirtz VJ, Hogerzeil HV, Gray AL, et al. Essential medicines for universal health coverage. Lancet. 2017;389(10067):403–476.
   PubMedGoogle Scholar
• INAHTA. INAHTA impact assessment study 2020. Canada: The International Network of Agencies for HealthTechnology Assessment (INAHTA). Vol. 2020.
   Google Scholar
• Oortwijn W, van Oosterhout S, Kapiriri L. Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries. Int J Technol Assess Health Care. 2020;36(4):440–444.
   Web of Science ®Google Scholar
• Hollingworth S, Fenny AP, Yu S-Y, et al. Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis. Cost Eff Resour Allocation. 2021;19(1):39.
   PubMed Web of Science ®Google Scholar
• Surgey G, Chalkidou K, Reuben W, et al. Introducing health technology assessment in Tanzania. Int J Technol Assess Health Care. 2020;36(2):80–86.
   PubMed Web of Science ®Google Scholar
• Almomani E, Alabbadi I, Fasseeh A, et al. Implementation road map of health technology assessment in middle-income countries: the case of jordan. Value Health Reg Issues. 2021;25:126–134.
   PubMedGoogle Scholar
• Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–473.
   PubMed Web of Science ®Google Scholar
• Anderson S, Allen P, Peckham S, et al. Asking the right questions: scoping studies in the commissioning of research on the organisation and delivery of health services. Health Res Policy Syst. 2008;6(1):7.
   PubMedGoogle Scholar
• Aromataris E, Munn Z JBI manual for evidence synthesis. 2020.
   Google Scholar
• Schneider H, Maleka N. Patterns of authorship on community health workers in low-and-middle-income countries: an analysis of publications (2012–2016). BMJ Glob Health. 2018;3(3):e000797.
   PubMed Web of Science ®Google Scholar
• English KM, Pourbohloul B. Increasing health policy and systems research capacity in low- and middle-income countries: results from a bibliometric analysis. Health Res Policy Syst. 2017;15(1):64.
   PubMedGoogle Scholar
• McGregor S, Henderson KJ, Kaldor JM. Capacity building in longitudinal HIV research. Lancet Global Health. 2015;3(1):e18–e9
   PubMed Web of Science ®Google Scholar
• Vassall A, Mangham-Jefferies L, Gomez GB, et al. and supply constraints into economic evaluations in low-income and middle-income countries. Health Econ. 2016;25(S1):95–115.
   PubMedGoogle Scholar
• Watson M. Panel discussion on the application of MCDA tools. Cost Eff Resour Allocation. 2018;16(1):40.
   PubMedGoogle Scholar
• Fasseeh A, Karam R, Jameleddine M, et al. Implementation of health technology assessment in the middle East and North Africa: comparison between the current and preferred status. Front Pharmacol. 2020;11:15. Internet.
   PubMed Web of Science ®Google Scholar
• Kim T, Sharma M, Teerawattananon Y, et al. Addressing challenges in health technology assessment institutionalization for furtherance of universal health coverage through south-south knowledge exchange: lessons from Bhutan, Kenya, Thailand, and Zambia. Value Health Reg Issues. 2021;24:187–192.
   PubMedGoogle Scholar
• MacQuilkan K, Baker P, Downey L, et al. Strengthening health technology assessment systems in the global south: a comparative analysis of the HTA journeys of China, India and South Africa. Glob Health Action. 2018;11(1):1527556.
   PubMed Web of Science ®Google Scholar
• O’Brien N, Li R, Isaranuwatchai W, et al. How can we make better health decisions a best buy for all?: commentary based on discussions at iDSI roundtable on 2 (nd) May 2019 London, UK. Gates Open Res. 2019;3:1543.
   PubMedGoogle Scholar
• Li R, Hernandez-Villafuerte K, Towse A, et al. Mapping priority setting in health in 17 countries across Asia, Latin America, and sub-Saharan Africa. Health Syst Reform. 2016;2(1):71–83.
   PubMed Web of Science ®Google Scholar
• Kumar MB, Taegtmeyer M, Madan J, et al. How do decision-makers use evidence in community health policy and financing decisions? A qualitative study and conceptual framework in four African countries. Health Policy Plan. 2020;35(7):799–809.
   PubMed Web of Science ®Google Scholar
• Tantivess S, Chalkidou K, Tritasavit N, et al. Health technology assessment capacity development in low- and middle-income countries: experiences from the international units of HITAP and NICE. F1000Res. 2017;6:2119.
   PubMedGoogle Scholar
• Babigumira JB, Jenny AM, Bartlein R, et al. Health technology assessment in low- and middle-income countries: a landscape assessment. J Pharm Health Serv Res. 2016;7(1):37–42.
   Google Scholar
• Sharma M, Teerawattananon Y, Dabak SV, et al. A landscape analysis of health technology assessment capacity in the association of South-East Asian nations region. Health Res Policy Syst. 2021;19(1):19.
   PubMed Web of Science ®Google Scholar
• Kaló Z, Gheorghe A, Huic M, Kaló Z, Gheorghe A, Huic M, Csanádi M, Kristensen FB. HTA Implementation. Roadmap in Central and Eastern European Countries. Health Econ. 2016;25(S1):179–192.
   PubMedGoogle Scholar
• Al Rabayah AA, Al Froukh RF, Sawalha RD. A capacity-building programme in health technology assessment for hospital pharmacists in a low- to middle-income country. J Pharm Health Serv Res. 2018;9(3):275–280.
   Google Scholar
• Odoch WD, Dambisya Y, Peacocke E, et al. The role of government agencies and other actors in influencing access to medicines in three East African countries. Health Policy Plan. 2021;36(3):312–321.
   PubMed Web of Science ®Google Scholar
• Wasir R, Irawati S, Makady A, et al. The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: insights from multiple stakeholders. PLoS One. 2019;14(11):e0225626.
   PubMed Web of Science ®Google Scholar
• Vo T. Health technology assessment in developing countries: a brief introduction for Vietnamese health-care policymakers. Asian J Pharm. 2018. Jan-March 2018 (Special Issue), S1-7.
   Web of Science ®Google Scholar
• Csanádi M, Inotai A, Oleshchuk O, et al. Health technology assessment implementation in Ukraine: current status and future perspectives. Int J Technol Assess Health Care. 2019;35(5):393–400.
   PubMed Web of Science ®Google Scholar
• Dabak SV, Teerawattananon Y, Win T. From design to evaluation: applications of health technology assessment in myanmar and lessons for low or lower middle-income countries. Int J Technol Assess Health Care. 2019;35(6):461–466.
   PubMed Web of Science ®Google Scholar
• Zegeye EA, Reshad A, Bekele EA, et al. The state of health technology assessment in the ethiopian health sector: learning from recent policy initiatives. Value Health Reg Issues. 2018;16:61–65.
   PubMedGoogle Scholar
• Zegeye EA, Mbonigaba J, Kaye SB, et al. Economic evaluation in ethiopian healthcare sector decision making: perception, practice and barriers. Appl Health Econ Health Policy. 2017;15(1):33–43.
   PubMed Web of Science ®Google Scholar
• Addo R, Goodall S, Hall J, et al. Assessing the capacity of Ghana to introduce health technology assessment: a systematic review of economic evaluations conducted in Ghana. Int J Technol Assess Health Care. 2020;36(5):500–507.
   PubMed Web of Science ®Google Scholar
• Addo R, Hall J, Haas M, et al. The knowledge and attitude of Ghanaian decision-makers and researchers towards health technology assessment. Soc Sci Med. 2020;250:112889.
   PubMed Web of Science ®Google Scholar
• Uzochukwu BSC, Okeke C, O’Brien N, et al. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders’ capacity, needs, policy areas of demand and perspectives in Nigeria. Global Health. 2020;16(1):58.
   PubMed Web of Science ®Google Scholar
• Dabak SV, Pilasant S, Mehndiratta A, et al. Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India. Health Res Policy Syst. 2018;16(1):115.
   PubMedGoogle Scholar
• Piniazhko O. Pharmaceutical system in Ukraine: implementation of external reference pricing, reimbursement programs and health technology assessment. Pharmacia. 2018;65(2):28-39.
   Web of Science ®Google Scholar
• Jain S, Rajshekar K, Sohail A, et al. Department of health research-health technology assessment (DHR-HTA) database: national prospective register of studies under HTAIn. Indian J Med Res. 2018;148(3):258–261.
   PubMed Web of Science ®Google Scholar
• Bakre MM. Suggestions to make health technology assessment in India an efficient process. Value Health Reg Issues. 2021;24:214–215.
   PubMedGoogle Scholar
• Sundararajan S, Pattanshetty S, Aatre KR, et al. Stakeholder perception of health technology assessment in industrial setting. Indian J Public Health Res Dev. 2019;10(4):309–312
   Google Scholar
• Mukherjee K. A SMART framework for HTA capability development: lessons from India. Health Policy Technol. 2020;9(1):42–44.
   Web of Science ®Google Scholar
• Dwivedi R, Athe R, Pati S, et al. Mapping of health technology assessment (HTA) teaching and training initiatives: landscape for evidence-based policy decisions in India. J Family Med Prim Care. 2020;9(11):5458–5467.
   PubMedGoogle Scholar
• Prinja S, Jyani G, Gupta N, et al. Adapting health technology assessment for drugs, medical devices, and health programs: methodological considerations from the Indian experience. Expert Rev Pharmacoecon Outcomes Res. 2021;21(5):859–868.
   PubMed Web of Science ®Google Scholar
• Prinja S, Downey LE, Gauba VK, et al. Health technology assessment for policy making in India: current scenario and way forward. Pharmacoecon Open. 2018;2(1):1–3.
   PubMed Web of Science ®Google Scholar
• Downey LE, Dabak S, Eames J, et al. Building capacity for evidence-informed priority setting in the indian health system: an international collaborative experience. Health Policy open. 2020; 1: 100004.
   PubMedGoogle Scholar
• Downey LE, Mehndiratta A, Grover A, et al. Institutionalising health technology assessment: establishing the medical technology assessment board in India. BMJ Glob Health. 2017;2(2):e000259.
   PubMed Web of Science ®Google Scholar
• Dang A, Dang D, Vallish BN. Importance of evidence-based health insurance reimbursement and health technology assessment for achieving universal health coverage and improved access to health in India. Value Health Reg Issues. 2021;24:24–30.
   PubMedGoogle Scholar
• Dang A, Vallish BN. Real world evidence: an Indian perspective. Perspect Clin Res. 2016;7(4):156–160.
   PubMedGoogle Scholar
• Singh D, Luz ACG, Rattanavipapong W, et al. Designing the free drugs list in Nepal: a balancing act between technical strengths and policy processes. MDM Policy Pract. 2017;2(1):2381468317691766.
   Google Scholar
• Gheorghe A, Gad M, Ismail SA, et al. Capacity for health economics research and practice in Jordan, Lebanon, the occupied Palestinian territories and Turkey: needs assessment and options for development. Health Res Policy Syst. 2020;18(1):99.
   PubMed Web of Science ®Google Scholar
• Swami S, Srivastava T. Role of culture, values, and politics in the implementation of health technology assessment in india: a commentary. Value Health. 2020;23(1):39–42.
   PubMed Web of Science ®Google Scholar
• Hammad EA. The use of economic evidence to inform drug pricing decisions in Jordan. Value Health. 2016;19(2):233–238.
   PubMed Web of Science ®Google Scholar
• Alabbadi I, Almomani E, Alshazili M. Drug selection for formulary inclusion: an exploratory case study of oncology medicines in Jordan. Value Health Reg Issues. 2020;21:211–221.
   PubMedGoogle Scholar
• Mukherjee K. Integrating technology, innovation and policy: COVID-19 and HTA. Health Policy Technol. 2021;10(1):16–20.
   Web of Science ®Google Scholar
• Hampson G, Henshall C, Towse A. ASSESSING VALUE, BUDGET IMPACT, AND AFFORDABILITY IN ASIA. Int J Technol Assess Health Care. 2017;33(2):315–322.
   PubMed Web of Science ®Google Scholar
• Wilkinson T, Sculpher MJ, Claxton K, et al. The international decision support initiative reference case for economic evaluation: an aid to thought. Value Health. 2016;19(8):921–928.
   PubMed Web of Science ®Google Scholar
• Towse A HTA’s macro role in health care systems https://www.slideshare.net/OHENews/macro-hta-presentation-ispor-beijing-towse-20142014
   Google Scholar
• Teerawattananon Y, Luz K, Yothasmutra C, et al. HISTORICAL DEVELOPMENT OF THE HTAsiaLINK NETWORK AND ITS KEY DETERMINANTS OF SUCCESS. Int J Technol Assess Health Care. 2018;34(3):260–266.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. WHO HTA Survey 2021 WHO, Geneva: WHO; 2021 [ Available from: https://www.who.int/teams/health-systems-governance-and-financing/economic-analysis/health-technology-assessment-and-benefit-package-design/survey-homepage.
   Google Scholar
• Bouttell J, Grieve E, Hawkins N The role of development-focused health technology assessment in optimising science, technology and innovation to achieve SDG3. Science, Technology and Innovation for Meeting Sustainable Development Goals: OUP; in press.
   Google Scholar
• Elshaug AG, Hiller JE, Tunis SR, et al. Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices. Aust New Zealand Health Policy. 2007;4(1):23.
   PubMedGoogle Scholar
• Henshall C, Schuller T, Mardhani-Bayne L. Using health technology assessment to support optimal use of technologies in current practice: the challenge of “disinvestment”. Int J Technol Assess Health Care. 2012;28(3):203–210.
   PubMed Web of Science ®Google Scholar
• Esandi ME, Gutiérrez-Ibarluzea I, Ibargoyen-Roteta N, et al. An evidence-based framework for identifying technologies of no or low-added value (NLVT). Int J Technol Assess Health Care. 2020;36(1):50–57.
   PubMed Web of Science ®Google Scholar
• Esmail R, Hanson H, Holroyd-Leduc J, et al. Knowledge translation and health technology reassessment: identifying synergy. BMC Health Serv Res. 2018;18(1):674.
   PubMedGoogle Scholar
• Fronsdal KB, Facey K, Klemp M, et al. Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes. Int J Technol Assess Health Care. 2010;26(3):309–316.
   PubMed Web of Science ®Google Scholar
• Farhana Kamaruzaman H, Grieve E, Wu O Disinvestment in healthcare: a scoping review of systematic reviews. 2022.
   Google Scholar
• CGD. [ cited 2020]. Available from: https://www.cgdev.org/blog/priority-setting-better-health-international-decision-support-initiative?utm_source=200428&utm_medium=cgd_email&utm_campaign=cgd_weekly.
   Google Scholar
• Cacciatore P, Specchia ML, Solinas MG, et al. The organizational domain in HTA reports: towards a technology-oriented assessment. Eur J Public Health. 2020;30(2):219–223.
   PubMed Web of Science ®Google Scholar
• Lee A, Skött LS, Hansen HP. Organizational and patient-related assessments in HTAs: state of the art. Int J Technol Assess Health Care. 2009;25(4):530–536.
   PubMed Web of Science ®Google Scholar
• Skivington K, Matthews L, Simpson SA, et al. A new framework for developing and evaluating complex interventions: update of medical research council guidance. BMJ. 2021;374:n2061.
   PubMed Web of Science ®Google Scholar
• Heggie R, Boyd K, Wu O. How has implementation been incorporated in health technology assessments in the United Kingdom? A systematic rapid review. Health Res Policy Syst. 2021;19(1):118.
   PubMed Web of Science ®Google Scholar
• OHE TA. 2020. [ cited 2020]. Available from: https://www.ohe.org/news/unpacking-black-box-payer-policy-demand-side-approach-equitable-uptake-cost-effective-health-0.
   Google Scholar
• Towse A Unpacking the Black Box of Payer Policy: a Demand-Side Approach for Equitable Uptake of Cost-Effective Health Innovation. Office of Health Economics. 2020. Available from: https://www.ohe.org/news/unpacking-black-box-payer-policy-demand-side-approach-equitable-uptake-cost-effective-health-0
   Google Scholar
• Bouttell J, Grieve E, Hawkins N (2020) The role of development-focused health technology assessment in optimizing science, technology, and innovation to achieve sustainable development goal 3. In: Adenle AA, Chertow MR, Moors EHM and Pannell DJ (editors) Science, Technology, and Innovation for Sustainable Development Goals: Insights from Agriculture, Health, Environment, and Energy. Oxford University Press: New York, NY. ISBN 9780190949501
   Google Scholar
• Cylus J, Papanicolas I, Smith P. Health System Efficiency: how to make measurement matter for policy and management. London editor:WHO;2016.
   Google Scholar
• Velasco Garrido M, Gerhardus A, Rottingen JA, et al. Developing health technology assessment to address health care system needs. Health Policy. 2010;94(3):196–202.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya O, Khor S, McGahan A, et al. Innovative health service delivery models in low and middle income countries - what can we learn from the private sector? Health Res Policy Syst. 2010;8(1):24.
   PubMedGoogle Scholar
• Chalkidou K, Towse A, Silverman R, et al. Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB. BMJ Glob Health. 2020;5(4):e002061.
   PubMed Web of Science ®Google Scholar
• Al-Ajlouni R, Al Rabayah A. Will jordan be closer to UHC after the COVID-19 pandemic? J Glob Health. 2020;10(2):020360.
   PubMed Web of Science ®Google Scholar
• OECD. Using routinely collected data to inform pharmaceutical policies. 2019.
   Google Scholar
• Gilardino RE, Mejía A, Guarín D, et al. Implementing Health technology assessments in latin america: looking at the past, mirroring the future. A perspective from the ISPOR health technology assessment roundtable in Latin America. Value Health Reg Issues. 2020;23:6–12.
   PubMedGoogle Scholar
• Devex. Africa CDC Q&A: africa CDC official on bringing African expertise to African emergencies | devex: devex
   Google Scholar
• Chang H-J. Institutions and economic development: theory, policy and history. J Institutional Econ. 2010;7(4):473–498
   Web of Science ®Google Scholar
• Glassman A, Chalkidou K, 2012. ”Priority-Setting in Health: Building Institutions for Smarter Public Spending,” Working Papers id:5043, eSocialSciences.
   Google Scholar
• Glassman A, Chalkidou K, Giedion U, et al. Priority-setting institutions in health: recommendations from a center for global development working group. Glob Heart. 2012;7(1):13–34.
   PubMedGoogle Scholar
• Lea L. Which policies increase value for money in health care? Paris: OECD Publishing; 2018.
   Google Scholar
• Löblová O. What has health technology assessment ever done for us? J Health Serv Res Policy. 2017;23(2):134–136.
   PubMed Web of Science ®Google Scholar
• Jacob R, McGregor M. Assessing the impact of health technology assessment. Int J Technol Assess Health Care. 1997;13(1):68–80.
   PubMed Web of Science ®Google Scholar
• Buxton M, Hanney S. How can payback from health services research be assessed? J Health Ser Res. 1996;1(1):35–43.
   PubMedGoogle Scholar
• Davies L, Drummond M, Papanikolaou P. Prioritizing investments in health technology assessment. Can we assess potential value for money? Int J Technol Assess Health Care. 2000;16(1):73–91
   PubMed Web of Science ®Google Scholar
• Wanke M An exploratory review of evaluations of health technology assessment agencies. 2006;Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #16.
   Google Scholar
• Lafortune L, Farand L, Mondou I, et al. Assessing the performance of health technology assessment organizations: a framework. Int J Technol Assess Health Care. 2008;24(1):76–86.
   PubMed Web of Science ®Google Scholar
• Guthrie S, Hafner M, Bienkowska-Gibbs T, et al. Returns on research funded under the nihr health technology assessment (HTA) programme: economic analysis and case studies. Rand Health Q. 2016;5(4):5.
   PubMedGoogle Scholar
• INAHTA. INAHTA Impact Framework http://www.inahta.org/hta-tools-resources/briefs/#Impact [
   Google Scholar
• Schumacher I, Zechmeister I. ASSESSING THE IMPACT OF HEALTH TECHNOLOGY ASSESSMENT ON THE AUSTRIAN HEALTHCARE SYSTEM. Int J Technol Assess Health Care. 2012;29(1):84–91.
   PubMed Web of Science ®Google Scholar
• de Sola-Morales O, Granados A. Health technology assessment in Catalonia: an overview of past and future perspectives. Int J Technol Assess Health Care. 2009;25(Suppl 1):88–93.
   PubMedGoogle Scholar
• Sigmund H, Kristensen FB. Does health technology assessment benefit health services and politics? Eur J Health Econ. 2002;3(1):54–58.
   PubMedGoogle Scholar
• Yazdizadeh B, Mohtasham F, Velayati A. Impact assessment of Iran’s health technology assessment programme. Health Res Policy Syst. 2018;16(1):15.
   PubMedGoogle Scholar
• Roza S, Junainah S, Izzuna MMG, et al. Health technology assessment in malaysia: past, present, and future. Int J Technol Assess Health Care. 2019;35(6):446–451.
   PubMed Web of Science ®Google Scholar
• Lipska I, McAuslane N, Leufkens H, et al. A DECADE OF HEALTH TECHNOLOGY ASSESSMENT IN POLAND. Int J Technol Assess Health Care. 2017;33(3):350–357.
   PubMed Web of Science ®Google Scholar
• Kao K-L, Huang L-Y, Wu Y-H, et al. Outcomes and impacts of 10-year HTA implementation in Taiwan. Int J Technol Assess Health Care. 2019;35(6):441–445.
   PubMed Web of Science ®Google Scholar
• Kristin E, Endarti D, Khoe LC, et al. Economic evaluation of adding bevacizumab to chemotherapy for metastatic colorectal cancer (mCRC) patients in Indonesia. Asian Pac J Cancer Prev. 2021;22(6):1921–1926.
   PubMedGoogle Scholar
• Munn Z, Peters MDJ, Stern C, et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143.
   PubMed Web of Science ®Google Scholar
• Grol R, Kagay CR, Geppert JJ. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care. 2001;39(1):39.
   PubMedGoogle Scholar